Keyphrases
India
85%
Adjusted Odds Ratio
68%
Invasive Aspergillosis
42%
Amphotericin B
42%
Syphilis
42%
Antiretroviral Adherence
42%
AIDS/HIV
42%
Receiving Care
42%
Same-sex Behavior
42%
Private Care
42%
Pune
42%
Private Clinic
42%
Peripherally Inserted Central Catheter
42%
Mumbai
42%
Genital Ulcer Disease
42%
Itraconazole
42%
Sexually Transmitted Infection Clinic
42%
Virologic Suppression
42%
Protease Inhibitor Resistance
28%
Nonnucleoside Reverse Transcriptase Inhibitor Resistance
28%
Aspergillosis
18%
Hijra
17%
Infection Rate
17%
Risk Behavior
17%
HIV Prevalence
17%
Combination Therapy
12%
Antiretroviral Therapy Regimens
11%
Antiretroviral Therapy
11%
Men Who Have Sex with Men
8%
Prevalence Trends
8%
Clinical Data
8%
HIV-positive
8%
Disease Rate
8%
Standardized Questionnaire
8%
Prevalence Risk
8%
Eunuchs
8%
Sexually Transmitted Infection Screening
8%
Low Prevalence
8%
Infection Risk
8%
Gonorrhea
8%
Condoms
8%
Same-sex
8%
Demographic Risk
8%
High-risk Sexual Behavior
8%
Laboratory Procedures
8%
Sex Risk
8%
Behavioral Data
8%
Laboratory Data
8%
HIV Risk
8%
Group Questionnaire
8%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
85%
Odds Ratio
57%
Private Hospital
57%
Aspergillosis
42%
Multi-Drug-Resistant Tuberculosis
42%
Nephrotoxicity
42%
Hazard Ratio
42%
Virus Load
42%
South Africa
42%
Peripherally Inserted Central Venous Catheter
42%
Amphotericin B
42%
Case Management
42%
Self Report
42%
Patient Compliance
25%
Confidence Interval
21%
Creatinine
18%
Hemodialysis
18%
Adverse Drug Reaction
12%
Practice Guideline
12%
Drug Therapy
7%
Drug Concentration
7%
Nursing Intervention
6%
Treatment Outcome
6%
Mortality Rate
6%
Symptom
6%
Autologous Bone Marrow Transplantation
6%
Case Manager
6%
Proportional Hazards Model
6%
Treatment Duration
6%
Prevalence
6%
Mixed Infection
6%
Fatality
6%
Allogenic Bone Marrow Transplantation
6%
Organ Transplantation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Amphotericin B
85%
HIV
85%
Aspergillosis
58%
Invasive Aspergillosis
42%
Itraconazole
42%
Retrospective Study
42%
Nephrotoxicity
42%
Hemodialysis
32%
Creatinine
32%
Combination Therapy
15%
Human Immunodeficiency Virus 1
14%
Epileptic Absence
14%
Nonnucleoside Reverse Transcriptase Inhibitor
14%
Pharmacotherapy
14%
RNA Directed DNA Polymerase Inhibitor
14%
Self-Medication
14%
Proteinase Inhibitor
14%
Fatality
10%
Mortality Rate
10%
Intravenous Therapy
8%
Catheter Complication
8%
Clinical Study
5%
Randomized Clinical Trial
5%
